The global transplant diagnostics market is projected to reach USD 4.91 billion by 2023 from 3.44 billion in 2018, at a CAGR of 7.4%. Factors such as the increasing public-private funding for target research activities, growing burden of infectious diseases, increasing number of transplant procedures, and increasing public awareness about organ donation and transplantation across emerging countries are driving the growth of the transplant diagnostics market.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=2531061
What This Report Will Provide?
The study involved four major activities in estimating the current size of the transplant diagnostics market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
On the basis of product, the transplant diagnostics market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment is expected to account for the highest growth rate of the transplant diagnostics market during the forecast period. The high growth can be attributed to the expansion in the application horizons of molecular assay techniques in transplant diagnostics (owing to better accuracy, high turnaround time, capability to analyze multiple samples in a single process, and early detection of donor-recipient incompatibility).
Browse and in-depth TOC on “Transplant Diagnostics Market”
60 – Figures
203 – Pages
Based on technology, the transplant diagnostics market is segmented into molecular and non-molecular assays. The molecular assays segment is expected to account for the highest growth rate of the transplant diagnostics market during the forecast period. The high growth can be attributed to the demand for molecular assays and its varied applications in patient profiling, rising public-private investments to support product development, increasing clinical evidence to establish clinical efficacy of molecular assays, and technological advancements (such as PCR and NGS).
On the basis of transplant type, the transplant diagnostics market is segmented into solid organ, stem cell, and soft tissue transplantation. The solid organ transplantation segment is expected to account for the highest growth rate of the transplant diagnostics market during the forecast period. The high growth can be attributed to the increasing number of solid organ transplantation procedures and supportive government regulations to increase organ donations across major healthcare markets.
Based on application, the global transplant diagnostics market is segmented into diagnostic and research applications. The diagnostic applications market is further segmented into pre-transplantation (infectious diseases testing, histocompatibility testing, and blood profiling) and post-transplantation diagnostic applications. The pre-transplantation is expected to account for the highest growth rate of the transplant diagnostics market in 2018. The high CAGR of this segment is attributed to ongoing technological advancements in the field of molecular assay techniques (such as SSO, PCR, and NGS) and increasing adoption of molecular assay procedures for pathogen detection and histocompatibility testing.
On the basis of end user, the independent reference laboratories segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the rapid modernization and automation of diagnostic laboratories and growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.